<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23-molecules-24-02603">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Stoddart</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Galkina</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Joshi</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Kosikova</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Moreno</surname>
    <given-names>M.E.</given-names>
   </name>
   <name>
    <surname>Rivera</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Sloan</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Reeve</surname>
    <given-names>A.B.</given-names>
   </name>
   <name>
    <surname>Sarafianos</surname>
    <given-names>S.G.</given-names>
   </name>
   <name>
    <surname>Murphey-Corb</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Oral administration of the nucleoside EFdA (4′-ethynyl-2-fluoro-2′-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaque</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2015</year>
  <volume>59</volume>
  <fpage>4190</fpage>
  <lpage>4198</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.05036-14</pub-id>
  <pub-id pub-id-type="pmid">25941222</pub-id>
 </element-citation>
</ref>
